Attitudes toward the diagnosis and disclosure of dementia among family caregivers and primary care physicians

The Gerontologist
Cathleen M ConnellMargaret L Hudson

Abstract

This study examined attitudes of caregivers and physicians toward assessing and diagnosing dementia, with an emphasis on how a diagnosis is disclosed. Seventeen focus group interviews were conducted with caregivers or physicians from three sites; 52 caregivers participated in nine interviews (three each at the three sites), and 39 physicians participated in eight interviews (three each at two sites; two at one site). Structured interview protocols were used to assess diagnostic disclosure, first reactions, and suggestions for improving the diagnostic process. Caregivers recounted a highly negative emotional response to the disclosure, whereas many physicians reported that families handled the information well. Caregivers expressed a range of preferences for how the diagnosis should have been disclosed, from a direct approach to having the physician ease them into the results. Whenever possible, physicians should consult with the patient and family at the outset of the diagnostic process to better understand their preferences for diagnostic disclosure. Addressing diagnostic disclosure as part of physician education programs on dementia is recommended.

References

Apr 2, 1992·The New England Journal of Medicine·M A Drickamer, M S Lachs
May 1, 1989·Journal of General Internal Medicine·R A Silliman
Mar 1, 1994·Journal of Health and Social Behavior·M R Haug
Aug 1, 1996·Journal of the American Geriatrics Society·C M Connell, M P Gallant
Aug 31, 1996·BMJ : British Medical Journal·C P MaguireD O'Neill
Sep 25, 1999·The Gerontologist·L BoiseL Congleton
Jun 7, 2000·Journal of General Internal Medicine·C M Clancy
Mar 10, 2001·The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques·A P Smith, B L Beattie
Jan 17, 2002·Journal of Geriatric Psychiatry and Neurology·N L Foster

❮ Previous
Next ❯

Citations

Apr 24, 2007·Zeitschrift für Gerontologie und Geriatrie·G LämmlerE Steinhagen-Thiessen
Feb 1, 2011·Irish Journal of Medical Science·C O'Connor
Jul 7, 2011·International Psychogeriatrics·Deliane van VlietFrans R J Verhey
Jun 15, 2007·Aging & Mental Health·Emily C Kissel, Brian D Carpenter
Sep 7, 2007·Alzheimer Disease and Associated Disorders·Cathleen M ConnellSara J McLaughlin
Sep 7, 2007·Alzheimer Disease and Associated Disorders·Carol E FranzLadson Hinton
May 29, 2009·Alzheimer Disease and Associated Disorders·Cathleen M ConnellDapo Akinleye
Mar 15, 2011·Alzheimer Disease and Associated Disorders·James E GalvinJohn C Morris
Feb 10, 2007·Dementia and Geriatric Cognitive Disorders·Gabriela StoppeLienhard Maeck
Jun 19, 2010·American Journal of Alzheimer's Disease and Other Dementias·Alexandra K Zaleta, Brian D Carpenter
May 3, 2008·BMC Health Services Research·Jan LecouturierMartin P Eccles
Sep 5, 2013·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Jeanette C ProrokDallas P Seitz
Dec 22, 2012·Canadian Geriatrics Journal : CGJ·Faranak AminzadehDebbie Ayotte
Apr 22, 2014·Clinical Interventions in Aging·James E GalvinCheryl Wingbermuehle
May 20, 2015·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·UNKNOWN Alzheimer’s Association
May 3, 2014·International Psychogeriatrics·Maree MastwykBriony Dow
Feb 2, 2011·International Psychogeriatrics·Louise RobinsonJill Manthorpe
May 22, 2013·Progress in Neurobiology·Marjolein E de Vugt, Frans R J Verhey
May 7, 2013·The Medical Clinics of North America·Pascal Antoine, Florence Pasquier
Oct 16, 2012·The American Journal of Geriatric Pharmacotherapy·Adrienne M GilliganEdward P Armstrong
Jan 6, 2016·Aging & Mental Health·Catherine QuinnLinda Clare
Jun 7, 2011·Clinics in Geriatric Medicine·Elizabeth Herskovits Castillo
Oct 1, 2007·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·John D FiskFrank J Molnar
Aug 18, 2009·Journal of the American Geriatrics Society·Cathleen M ConnellBrian D Carpenter
Jan 3, 2007·Journal of the American Geriatrics Society·Mary LessigSoo Borson
Jan 16, 2008·Journal of the American Geriatrics Society·Brian D CarpenterJohn C Morris
Nov 27, 2008·Australasian Journal on Ageing·Andrew L RobinsonPaul A Turner
Jun 1, 2011·International Journal of Geriatric Psychiatry·Pim van den DungenHein P J van Hout
Nov 29, 2012·Nursing & Health Sciences·Tarja VälimäkiAnne Koivisto
Dec 1, 2009·Journal of the American Geriatrics Society·Dorothy P HarrisMartin F Shapiro
Dec 18, 2014·Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society·Laura StokesGraham Stokes
Mar 18, 2015·International Psychogeriatrics·Sube Banerjee
Oct 27, 2012·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Perla WernerShmuel Eidelman
Sep 25, 2015·Journal of Alzheimer's Disease : JAD·Christophe LéonPierre Arwidson
Mar 8, 2011·International Journal of Nursing Studies·Francine DucharmeRenée Coulombe
Jul 9, 2016·International Journal of Geriatric Psychiatry·Richard Cheston, Ada Ivanecka
Sep 3, 2005·American Journal of Alzheimer's Disease and Other Dementias·Inge Cantegreil-KallenAntoine Flahault
Aug 15, 2014·American Journal of Alzheimer's Disease and Other Dementias·Christine J Jensen, Jennifer Inker
Jul 19, 2013·Journal of Health Services Research & Policy·Clare AbleyLouise Robinson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.